help button home button Am J Pathol JNCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guidoboni, M.
Right arrow Articles by Dolcetti, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guidoboni, M.
Right arrow Articles by Dolcetti, R.
(American Journal of Pathology. 2001;159:297-304.)
© 2001 American Society for Investigative Pathology


Regular Articles

Microsatellite Instability and High Content of Activated Cytotoxic Lymphocytes Identify Colon Cancer Patients with a Favorable Prognosis

Massimo Guidoboni*, Roberta Gafà{dagger}, Alessandra Viel*, Claudio Doglioni{ddagger}, Antonio Russo§, Alessandra Santini, Laura Del Tin*, Ettore Macrì{ddagger}, Giovanni Lanza{dagger}, Mauro Boiocchi* and Riccardo Dolcetti*

From the Division of Experimental Oncology 1,*
Centro di Riferimento Oncologico, Aviano; the Section of Anatomic Pathology,{dagger}
the Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara; the Division of Clinical Oncology,
S. Anna Hospital, Ferrara; the Department of Pathology,{ddagger}
City Hospital, Belluno; and the Analytical Epidemiology Section,§
Epidemiology Unit, Centro per lo Studio e la Prevenzione Oncologica, Firenze, Italy

Colorectal cancers with high-frequency microsatellite instability show peculiar clinicopathological features and a favorable clinical outcome. We investigated whether the improved prognosis for these cancers is related to the content of activated cytotoxic intraepithelial T lymphocytes. Microsatellite instability and the amount of activated cytotoxic lymphocytes were analyzed according to clinicopathological features, survival, and disease recurrence in 109 right-sided colon carcinomas from 245 consecutive patients with stage II/III colon cancer that underwent radical surgery. High-frequency microsatellite instability was found in 43% of stage II/III proximal colon cancers and was associated with significantly higher numbers of activated cytotoxic lymphocytes. High-frequency microsatellite instability, as well as the content of intratumoral-activated cytotoxic T lymphocytes correlated with improved overall and disease-free survival, particularly in patients with stage III tumors. Multivariate analysis revealed that patients with both features had a risk of death and relapse markedly lower than that associated with microsatellite status or intratumoral cytotoxic lymphocytes separately. The presence of local cytotoxic immune responses is probably the major determinant of the good clinical course of patients with microsatellite unstable colon cancer. Furthermore, high-frequency microsatellite instability coupled with a high content of intratumoral cytotoxic lymphocytes may identify a subset of colon cancer patients with a favorable clinical outcome, particularly in stage III disease.





This article has been cited by other articles:


Home page
GutHome page
C. Loddenkemper, D. Nagorsen, and M. Zeitz
Foxp3 and microsatellite stability phenotype in colorectal cancer
Gut, June 1, 2008; 57(6): 725 - 726.
[Full Text] [PDF]


Home page
GutHome page
S Le Gouvello, S Bastuji-Garin, N Aloulou, H Mansour, M-T Chaumette, F Berrehar, A Seikour, A Charachon, M Karoui, K Leroy, et al.
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas
Gut, June 1, 2008; 57(6): 772 - 779.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
I Zlobec and A Lugli
Prognostic and predictive factors in colorectal cancer
J. Clin. Pathol., May 1, 2008; 61(5): 561 - 569.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Morris, C. Platell, and B. Iacopetta
Tumor-Infiltrating Lymphocytes and Perforation in Colon Cancer Predict Positive Response to 5-Fluorouracil Chemotherapy
Clin. Cancer Res., March 1, 2008; 14(5): 1413 - 1417.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
E. L. Kurnat-Thoma
Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): Molecular Pathogenesis and Clinical Approaches to Diagnosis and Management for Nurses
Biol Res Nurs, January 1, 2008; 9(3): 185 - 199.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. E. Prizment, A. R. Folsom, J. R. Cerhan, A. Flood, J. A. Ross, and K. E. Anderson
History of Allergy and Reduced Incidence of Colorectal Cancer, Iowa Women's Health Study
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2357 - 2362.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G. Y. Locker, S. Hamilton, J. Harris, J. M. Jessup, N. Kemeny, J. S. Macdonald, M. R. Somerfield, D. F. Hayes, and R. C. Bast Jr
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
J. Clin. Oncol., November 20, 2006; 24(33): 5313 - 5327.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Melloni, C. Doglioni, A. Bandiera, A. Carretta, P. Ciriaco, G. Arrigoni, and P. Zannini
Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma
Ann. Thorac. Surg., June 1, 2006; 81(6): 2008 - 2013.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
J M Carethers
Prospective evaluation of fluorouracil chemotherapy based on the genetic makeup of colorectal cancer.
Gut, June 1, 2006; 55(6): 759 - 761.
[Full Text] [PDF]


Home page
JCOHome page
G. Lanza, R. Gafa, A. Santini, I. Maestri, L. Guerzoni, and L. Cavazzini
Immunohistochemical Test for MLH1 and MSH2 Expression Predicts Clinical Outcome in Stage II and III Colorectal Cancer Patients
J. Clin. Oncol., May 20, 2006; 24(15): 2359 - 2367.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. Benatti, R. Gafa, D. Barana, M. Marino, A. Scarselli, M. Pedroni, I. Maestri, L. Guerzoni, L. Roncucci, M. Menigatti, et al.
Microsatellite Instability and Colorectal Cancer Prognosis
Clin. Cancer Res., December 1, 2005; 11(23): 8332 - 8340.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Popat, R. Hubner, and R.S. Houlston
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
J. Clin. Oncol., January 20, 2005; 23(3): 609 - 618.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Duval, M. Raphael, C. Brennetot, H. Poirel, O. Buhard, A. Aubry, A. Martin, A. Krimi, V. Leblond, J. Gabarre, et al.
The mutator pathway is a feature of immunodeficiency-related lymphomas
PNAS, April 6, 2004; 101(14): 5002 - 5007.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
N. Takemoto, F. Konishi, K. Yamashita, M. Kojima, T. Furukawa, Y. Miyakura, K. Shitoh, and H. Nagai
The Correlation of Microsatellite Instability and Tumor-infiltrating Lymphocytes in Hereditary Non-polyposis Colorectal Cancer (HNPCC) and Sporadic Colorectal Cancers: the Significance of Different Types of Lymphocyte Infiltration
Jpn. J. Clin. Oncol., February 1, 2004; 34(2): 90 - 98.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Ishikawa, T. Fujita, Y. Suzuki, S. Okabe, Y. Yuasa, T. Iwai, and Y. Kawakami
Tumor-specific Immunological Recognition of Frameshift-mutated Peptides in Colon Cancer with Microsatellite Instability
Cancer Res., September 1, 2003; 63(17): 5564 - 5572.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
G.M. Nash, M. Gimbel, J. Shia, A.T. Culliford, D.R. Nathanson, M. Ndubuisi, Y. Yamaguchi, Z.S. Zeng, F. Barany, and P.B. Paty
Automated, Multiplex Assay for High-Frequency Microsatellite Instability in Colorectal Cancer
J. Clin. Oncol., August 15, 2003; 21(16): 3105 - 3112.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
F. Graziano and S. Cascinu
Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough?
Ann. Onc., July 1, 2003; 14(7): 1026 - 1038.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. A. Brown, R. L. Ward, P. Buckhaults, T. Liu, K. E. Romans, N. J. Hawkins, A. R. Bauskin, K. W. Kinzler, B. Vogelstein, and S. N. Breit
MIC-1 Serum Level and Genotype: Associations with Progress and Prognosis of Colorectal Carcinoma
Clin. Cancer Res., July 1, 2003; 9(7): 2642 - 2650.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Nakata, Y. Qing Wang, M. Yashiro, N. Nishioka, H. Tanaka, M. Ohira, T. Ishikawa, H. Nishino, and K. Hirakawa
Prognostic Value of Microsatellite Instability in Resectable Pancreatic Cancer
Clin. Cancer Res., August 1, 2002; 8(8): 2536 - 2540.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. Dolcetti, M. Guidoboni, A. Viel, M. Boiocchi, W. S. Samowitz, and M. L. Slattery
Correspondence re: Samowitz et al., Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol. Biomark. Prev., 10: 917-923, 2001
Cancer Epidemiol. Biomarkers Prev., May 1, 2002; 11(5): 499 - 500.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. van Rijnsoever, H. Elsaleh, B. Iacopetta, M. Guidoboni, A. Viel, L. Del Tin, M. Boiocchi, R. Dolcetti, R. Gafa, G. Lanza, et al.
Microsatellite Instability in Colorectal Cancer: Prognostic, Predictive or Both?
Am. J. Pathol., January 1, 2002; 160(1): 384 - 386.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Society for Investigative Pathology.